1. Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease

   • Serge Cremers
   • Patrick Garnero

   Current Opinion 12 September 2012 Pages: 2031 - 2058

   

2. Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis

   • Chandrashekhar Thukral
   • Adam Cheifetz
   • Mark A. Peppercorn

   Leading Article 12 September 2012 Pages: 2059 - 2065

3. Pilsicainide for Atrial Fibrillation

   • Koichiro Kumagai
   • Hideko Nakashima
   • Keijiro Saku

   Leading Article 12 September 2012 Pages: 2067 - 2073

   

4. Disease-Modifying Therapies in Alzheimer’s Disease

   • Michael Hüll
   • Mathias Berger
   • Michael Heneka

   Leading Article 12 September 2012 Pages: 2075 - 2093

   

5. Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

   • Joost P. van Melle
   • Peter de Jonge
   • Dirk J. van Veldhuisen

   Review Article 12 September 2012 Pages: 2095 - 2107

   

6. Rimonabant

   • Sheridan Henness
   • Dean M. Robinson
   • Katherine A. Lyseng-Williamson

   Adis Drug Profile 12 September 2012 Pages: 2109 - 2119

   

7. Rimonabant

   • Eli V. Gelfand

   Adis Drug Profile 12 September 2012 Pages: 2120 - 2120

8. Rimonabant

   • Uberto Pagotto

   Adis Drug Profile 12 September 2012 Pages: 2120 - 2121

9. Intravenous Droperidol

   • Kate McKeage
   • Dene Simpson
   • Antona J. Wagstaff

   Adis Drug Evaluation 12 September 2012 Pages: 2123 - 2147